Results 221 to 230 of about 38,631 (238)

Phosphodiesterase Type 5 Inhibitors for Premature Ejaculation: A Systematic Review and Meta-analysis

European Urology Focus, 2017
Marrissa Martyn-St James, Katy Cooper, Shijie Ren   +2 more
exaly  

CoMFA of benzyl derivatives of 2,1,3-benzo and benzothieno[3,2-a]thiadiazine 2,2-dioxides: clues for the design of phosphodiesterase 7 inhibitors

European Journal of Medicinal Chemistry, 2001
Ana Castro, Carmen Gil, VÍCTOR Segarra   +2 more
exaly  

Pharmacodynamics, pharmacokinetics and clinical efficacy of phosphodiesterase-5 inhibitors

Expert Opinion on Drug Metabolism and Toxicology, 2017
Isaac Yi Kim
exaly  

Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential

Bioorganic and Medicinal Chemistry, 2016
Nariman F Salakhutdinov, Olga I Lavrik
exaly  

Elucidation of Phosphodiesterase Type 5 Inhibitor Mechanism of Action

Journal of Urology, 2013
openaire   +2 more sources

The effect of phosphodiesterase inhibitors on the extinction of cocaine-induced conditioned place preference in mice

Journal of Psychopharmacology, 2012
Shervin Liddie, Karen L Anderson, Yossef Itzhak   +2 more
exaly  

The Relationship between Erectile Dysfunction and Lower Urinary Tract Symptoms and the Role of Phosphodiesterase Type 5 Inhibitors

European Urology, 2009
Tobias S Kohler
exaly  

Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors

Neuropharmacology, 1983
H Wachtel
exaly  

1-(2-Ethoxyethyl)-1H-pyrazolo[4,3-d]pyrimidines as potent phosphodiesterase 5 (PDE5) inhibitors

Bioorganic and Medicinal Chemistry Letters, 2010
John K Walker, Michael J Palmer, Brian R Bond   +2 more
exaly  

The effect of phosphodiesterase-5 inhibitors on cerebral blood flow in humans: A systematic review

Journal of Cerebral Blood Flow and Metabolism, 2018
Mathilde Pauls, Barry Moynihan, Thomas R Barrick   +2 more
exaly